Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2155 of 5804
-
Could a daily probiotic protect your gut while traveling abroad?
Disease control Not yet recruitingWith the improvement of living standards, travel has become a common form of leisure. However, travelers often face changes in living environments, dietary habits, and sleep schedules, all of which can impact the gut microbiota and lead to a range of health issues. Dietary chang…
Phase: NA • Sponsor: DiproBio (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New visual tool aims to prevent suicide in autistic teens
Symptom relief Not yet recruitingThis pilot randomized controlled trial will recruit 90 autistic adolescents aged 13-18 years with recent suicidal thoughts or behaviors from Geha Mental Health Center in Israel. Participants will be randomly assigned in a 1:1 ratio to either (1) the intervention group receiving t…
Phase: NA • Sponsor: College of Management Academic Studies • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Which injection works best for carpal tunnel pain? new study to find out
Symptom relief Not yet recruitingThis study aims to compare the efficacy and outcomes of perineural injection with 5% dextrose, local ozone and glucocorticoid injection in the management of carpal tunnel syndrome.
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could a common arthritis drug tame rare immune disease symptoms?
Disease control Recruiting nowBackground: Autosomal dominant hyper-IgE syndrome (HIES), also called Job syndrome, is a genetic disorder that affects the immune system. It can cause skin and lung infections and problems with blood vessels, connective tissues, and bones. People with HIES often have lupus-like …
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Cancer drug keytruda tested as possible treatment for long COVID brain fog
Symptom relief Not yet recruitingBackground: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from an acute COVID-19 infection may continue to have symptoms that persist for months or years. These can include neurological symptoms, such as headaches, loss of taste or smell, dizziness, or tr…
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Scientists use new tracer to peek at brain inflammation in Alzheimer's
Knowledge-focused Recruiting nowBackground: About 5 million adults in the United States have age-related brain disorders. These include Alzheimer disease (AD), mild cognitive impairment (MCI), and other dementias. The number of people with these disorders will likely increase as the population ages and life sp…
Phase: PHASE1 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
New drug aimed at stopping lung rejection in transplant patients
Disease control Not yet recruitingBackground: People who have lung transplants often survive 6 or 7 years. But some people develop donor-specific antibodies (DSA) after their transplants; antibodies are proteins that attack foreign invaders in the body. Antibodies typically kill viruses and other agents that can…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New heart procedure aims to zap stubborn arrhythmias
Disease control ENROLLING_BY_INVITATIONBackground: Ventricular arrhythmia is an abnormal pulse rhythm that starts in the lower part of the heart (ventricles). Treatment includes ablation; ablation uses heat to destroy small portions of the heart that are causing short circuits in the normal heartbeats. But ablation d…
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a ketamine metabolite replace opioids for acute pain?
Symptom relief Not yet recruitingBackground: Opioid drugs are often prescribed for acute and chronic pain. But these drugs are addictive, and they lead to more than 14,000 overdose deaths in the United States each year. Researchers want to find new drugs that relieve pain but are not addictive. This study will …
Phase: PHASE2 • Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New national registry aims to unlock secrets of Ultra-Rare childhood cancers
Knowledge-focused Recruiting nowBackground: All childhood cancers are rare, but some are called very rare. Very rare cancers are diagnosed in 2 or fewer out of 1 million people each year. Researchers want to gather data so they can learn more about these very rare cancers. They hope to use the data to develop …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
New study aims to find best therapy for angry outbursts in kids
Symptom relief Not yet recruitingBackground: Irritability is defined as proneness to anger that may impair a person s ability to function. It is a common reason for why some children need mental health care. Yet no therapies have been developed just to target irritability. Researchers want to compare different …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Could family and community support help slow cognitive decline?
Disease control Not yet recruitingMild cognitive impairment (MCI) may increase the risk of dementia. This study will evaluate an 8-week community-family mutual support intervention for adults aged 60 years or older with MCI. Participants will be randomly assigned to an intervention group or a control group. The c…
Phase: NA • Sponsor: Anhui Medical University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Walking and talking: new study tests group workouts for better mental health
Symptom relief Not yet recruitingCommon mental health disorders, like anxiety and depression, are widespread among the American population. The prevalence of mental health disorders among adults continues has consistently increased from previous decades and is now a major public health challenge. Data shows that…
Phase: NA • Sponsor: Emporia State University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Instagram vs. zoom: which platform builds better grief counselors?
Knowledge-focused Not yet recruitingThis randomized trial aims to compare the effectiveness of two digital educational approaches for perinatal grief counseling training among midwives and nurses working in perinatal care settings in Türkiye: a social media-based education program delivered through Instagram and an…
Phase: NA • Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis is a Phase 1, first-in-human, double-blind, placebo-controlled, adaptive-design, single-site study, involving dose exploration cohorts. During Part A, up to 4 cohorts, each consisting of approximately 14 healthy adult study participants, will be randomly allocated to receiv…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
App and home delivery aim to keep youth HIV-free
Prevention Not yet recruitingThe LYPS intervention is a multi-level intervention that combines: a) structural-level delivery of PrEP and PrEP services by a community health professional (CHP) at a designated place in the community being offered by the SC where PrEP is not yet provided (e.g., participant's ho…
Phase: NA • Sponsor: Westat • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
New drug shows promise for rare eye muscle disease in Long-Term trial
Disease control Not yet recruitingThe purpose of the study is to assess the long-term safety and efficacy of rozanolixizumab in adult study participants with ocular myasthenia gravis.
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Music therapy tested to lower preterm birth risk in black women
Symptom relief Not yet recruitingThis study will test a music intervention (MI) versus a sham control (SC) arm which only includes a verbal intervention, to determine if the effects of the music intervention will reduce the biological impact of chronic stress among pregnant Black women, reduce preterm birth, and…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Cuff-Limited exercise may boost blood health in anemic young women
Disease control Not yet recruitingPreventing iron deficiency anemia is essential for strengthening adolescent health and ensuring their full development. Strategies such as improving nutrition, expanding the availability of iron-fortified products, implementing pharmacological prevention, and raising awareness pl…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New digital coaching aims to keep heart failure patients out of hospital
Disease control Not yet recruitingMedication non-adherence leads to recurrent admissions, worsening symptoms, poor quality of life, and increased healthcare costs in an already overburdened health system. Existing adherence interventions in Pakistan are limited, mostly educational, and rarely guided by behavioura…
Phase: NA • Sponsor: Universiti Putra Malaysia • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC